BIOVF - Swedish Orphan Biovitrum AB reports Q4 earnings; issues FY23 soft guidance
- Swedish Orphan Biovitrum AB press release ( OTCPK:BIOVF ): Q4 GAAP EPS of SEK 4.68.
- Revenue of SEK 5.99B (+22.2% Y/Y).
- EBITA SEK 2,455M; EBITA margin 41%.
- EBIT SEK 1,916M.
-
Outlook 2023: Revenue is anticipated to grow by a low-to-mid single-digit percentage at CER; EBITA margin adjusted is anticipated to be at a low 30s percentage of revenue.
For further details see:
Swedish Orphan Biovitrum AB reports Q4 earnings; issues FY23 soft guidance